methyl 3-[5-(4-benzyloxybenzoyl)-2-isobutoxyphenyl]propionate | 1027202-56-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 3-[5-(4-benzyloxybenzoyl)-2-isobutoxyphenyl]propionate
• 英文别名: Methyl 3-[2-(2-methylpropoxy)-5-(4-phenylmethoxybenzoyl)phenyl]propanoate
• CAS: 1027202-56-7
• 化学式: C₂₈H₃₀O₅
• 分子量: 446.543
• InChiKey: HWBUROMGZXIKHQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  33
• 可旋转键数：
  12
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  61.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 3-[5-(4-benzyloxybenzoyl)-2-isobutoxyphenyl]propionate 在 sodium hydroxide 作用下， 以 丙酮 为溶剂， 反应 1.0h， 生成 3-[5-(4-Benzyloxy-benzoyl)-2-isobutoxy-phenyl]-propionic acid
  参考文献：
  名称：

  Discovery of Nonpeptidic Small-Molecule AP-1 Inhibitors:  Lead Hopping Based on a Three-Dimensional Pharmacophore Model

  摘要：

  We designed and synthesized small-molecule activator protein-1 (AP-1) inhibitors based on a three-dimensional (3D) pharmacophore model that we had previously derived from a cyclic decapeptide exhibiting AP-1 inhibitory activity. New AP-1 inhibitors with a 1-thia-4-azaspiro[4.5]decane or a benzophenone scaffold, which inhibit the DNA-binding and transactivation activities of AP-1, were discovered using a "lead hopping" procedure. An additional investigation of the benzophenone analogues confirmed the reliability of the pharmacophore model, its utility to discover AP-1 inhibitors, and the potency of the benzophenone derivatives as a lead series.

  DOI：

  10.1021/jm050550d
• 作为产物：
  描述：

  isobutyl 3-(2-isobutoxyphenyl)propionate 在 sodium chlorite 、 sodium dihydrogenphosphate 、 三氯化铝 、 草酰氯 、 偶氮二甲酸二异丙酯 、 双氧水 、 potassium carbonate 、 N,N-二甲基甲酰胺 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 15.5h， 生成 methyl 3-[5-(4-benzyloxybenzoyl)-2-isobutoxyphenyl]propionate
  参考文献：
  名称：

  Discovery of Nonpeptidic Small-Molecule AP-1 Inhibitors:  Lead Hopping Based on a Three-Dimensional Pharmacophore Model

  摘要：

  We designed and synthesized small-molecule activator protein-1 (AP-1) inhibitors based on a three-dimensional (3D) pharmacophore model that we had previously derived from a cyclic decapeptide exhibiting AP-1 inhibitory activity. New AP-1 inhibitors with a 1-thia-4-azaspiro[4.5]decane or a benzophenone scaffold, which inhibit the DNA-binding and transactivation activities of AP-1, were discovered using a "lead hopping" procedure. An additional investigation of the benzophenone analogues confirmed the reliability of the pharmacophore model, its utility to discover AP-1 inhibitors, and the potency of the benzophenone derivatives as a lead series.

  DOI：

  10.1021/jm050550d

文献信息

• Discovery of Nonpeptidic Small-Molecule AP-1 Inhibitors:  Lead Hopping Based on a Three-Dimensional Pharmacophore Model
  作者：Keiichi Tsuchida、Hisaaki Chaki、Tadakazu Takakura、Hironori Kotsubo、Tadashi Tanaka、Yukihiko Aikawa、Shunichi Shiozawa、Shuichi Hirono

  DOI：10.1021/jm050550d

  日期：2006.1.1

  We designed and synthesized small-molecule activator protein-1 (AP-1) inhibitors based on a three-dimensional (3D) pharmacophore model that we had previously derived from a cyclic decapeptide exhibiting AP-1 inhibitory activity. New AP-1 inhibitors with a 1-thia-4-azaspiro[4.5]decane or a benzophenone scaffold, which inhibit the DNA-binding and transactivation activities of AP-1, were discovered using a "lead hopping" procedure. An additional investigation of the benzophenone analogues confirmed the reliability of the pharmacophore model, its utility to discover AP-1 inhibitors, and the potency of the benzophenone derivatives as a lead series.